$KALA
KALA BIO, Inc.

2021 Q4 Form 10-Q Financial Statement

#000155837021015987 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $1.856M $3.067M $2.220M
YoY Change -17.07% 38.15% 53.0%
Cost Of Revenue $1.418M $908.0K $700.0K
YoY Change 4.26% 29.71% 4.48%
Gross Profit $438.0K $2.159M $1.520M
YoY Change -50.23% 42.04% 94.87%
Gross Profit Margin 23.6% 70.39% 68.47%
Selling, General & Admin $24.03M $25.35M $23.89M
YoY Change -9.23% 6.09% 56.37%
% of Gross Profit 5485.62% 1174.11% 1571.91%
Research & Development $29.03M $2.881M $3.468M
YoY Change 753.85% -16.93% -50.95%
% of Gross Profit 6628.08% 133.44% 228.16%
Depreciation & Amortization $212.0K $259.0K $220.0K
YoY Change -11.67% 17.73% 0.0%
% of Gross Profit 48.4% 12.0% 14.47%
Operating Expenses $47.25M $29.14M $28.06M
YoY Change 51.35% 3.83% 21.91%
Operating Profit -$46.82M -$26.07M -$25.84M
YoY Change 54.29% 0.89% 19.82%
Interest Expense -$2.064M $2.072M $2.157M
YoY Change -3.1% -3.94% -1.06%
% of Operating Profit
Other Income/Expense, Net -$2.056M
YoY Change
Pretax Income -$47.57M -$28.13M -$27.95M
YoY Change 52.9% 0.63% 20.58%
Income Tax
% Of Pretax Income
Net Earnings -$47.57M -$28.13M -$27.95M
YoY Change 52.9% 0.64% 20.59%
Net Earnings / Revenue -2562.93% -917.09% -1258.92%
Basic Earnings Per Share -$21.41
Diluted Earnings Per Share -$684.3K -$432.4K -$498.8K
COMMON SHARES
Basic Shares Outstanding 65.50M 64.97M 56.06M
Diluted Shares Outstanding 1.313M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $92.14M $124.5M $159.1M
YoY Change -39.98% -21.75% 63.01%
Cash & Equivalents $92.14M $124.5M $45.53M
Short-Term Investments $0.00 $0.00 $113.6M
Other Short-Term Assets $8.246M $4.245M $4.000M
YoY Change 174.87% 6.13% 81.82%
Inventory $8.639M $7.708M $7.538M
Prepaid Expenses
Receivables $15.35M $12.63M $7.455M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $124.4M $149.1M $178.2M
YoY Change -27.43% -16.32% 58.36%
LONG-TERM ASSETS
Property, Plant & Equipment $2.722M $3.142M $2.822M
YoY Change -14.02% 11.34% -91.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.04M $14.25M $15.80M
YoY Change -42.5% -9.83% 1.28%
Total Long-Term Assets $15.06M $44.73M $46.94M
YoY Change -70.01% -4.71% -3.22%
TOTAL ASSETS
Total Short-Term Assets $124.4M $149.1M $178.2M
Total Long-Term Assets $15.06M $44.73M $46.94M
Total Assets $139.4M $193.8M $225.1M
YoY Change -37.08% -13.9% 39.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.899M $5.845M $2.222M
YoY Change 184.16% 163.05% 1.0%
Accrued Expenses $20.99M $19.47M $15.85M
YoY Change 10.62% 22.8% 0.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $37.42M $27.20M $19.55M
YoY Change 68.38% 39.1% 8.61%
LONG-TERM LIABILITIES
Long-Term Debt $78.93M $78.49M $71.97M
YoY Change 9.25% 9.07% 1.5%
Other Long-Term Liabilities $6.272M $26.66M $27.50M
YoY Change -76.86% -3.06% -5.17%
Total Long-Term Liabilities $85.20M $105.2M $99.52M
YoY Change -14.27% 5.66% -0.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.42M $27.20M $19.55M
Total Long-Term Liabilities $85.20M $105.2M $99.52M
Total Liabilities $122.6M $132.3M $119.1M
YoY Change 0.83% 11.15% 0.9%
SHAREHOLDERS EQUITY
Retained Earnings -$542.4M -$494.8M -$368.7M
YoY Change 35.67% 34.22%
Common Stock $66.00K $65.00K $56.00K
YoY Change 11.86% 16.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.80M $61.47M $106.0M
YoY Change
Total Liabilities & Shareholders Equity $139.4M $193.8M $225.1M
YoY Change -37.08% -13.9% 39.81%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$47.57M -$28.13M -$27.95M
YoY Change 52.9% 0.64% 20.59%
Depreciation, Depletion And Amortization $212.0K $259.0K $220.0K
YoY Change -11.67% 17.73% 0.0%
Cash From Operating Activities -$27.90M -$26.08M -$25.65M
YoY Change 7.7% 1.69% 11.96%
INVESTING ACTIVITIES
Capital Expenditures -$12.00K -$329.0K -$540.0K
YoY Change -97.5% -39.07% 157.14%
Acquisitions
YoY Change
Other Investing Activities -$4.611M $5.050M -$57.05M
YoY Change -112.36% -108.85%
Cash From Investing Activities -$4.623M $4.721M -$57.60M
YoY Change -112.55% -108.2% 27328.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 160.0K 1.230M 750.0K
YoY Change -99.23% 64.0% -71.91%
NET CHANGE
Cash From Operating Activities -27.90M -26.08M -25.65M
Cash From Investing Activities -4.623M 4.721M -57.60M
Cash From Financing Activities 160.0K 1.230M 750.0K
Net Change In Cash -32.37M -20.13M -82.50M
YoY Change -202.27% -75.6% 303.42%
FREE CASH FLOW
Cash From Operating Activities -$27.90M -$26.08M -$25.65M
Capital Expenditures -$12.00K -$329.0K -$540.0K
Free Cash Flow -$27.89M -$25.75M -$25.11M
YoY Change 9.68% 2.56% 10.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001479419
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q3 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q3 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65085224
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58915375
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38150
dei Entity Registrant Name
EntityRegistrantName
KALA PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-0604595
dei Entity Address Address Line1
EntityAddressAddressLine1
490 Arsenal Way, Suite 120
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
996-5252
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
KALA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65500275
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124503000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77264000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
76276000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12630000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9604000
CY2021Q3 us-gaap Inventory Net
InventoryNet
7708000
CY2020Q4 us-gaap Inventory Net
InventoryNet
5229000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4245000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3006000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
149086000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
171379000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1530000
CY2020Q3 kala Product Revenue Cost
ProductRevenueCost
701000
CY2021Q3 us-gaap Assets
Assets
193814000
CY2020Q4 us-gaap Assets
Assets
221606000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5845000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1724000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19465000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18971000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1885000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3142000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3166000
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
11039000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
6219000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27339000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27853000
CY2021Q3 kala Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
3208000
CY2020Q4 kala Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
12989000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27195000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22225000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
26659000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
27143000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
78491000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72243000
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
105150000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
99386000
CY2021Q3 us-gaap Liabilities
Liabilities
132345000
CY2020Q4 us-gaap Liabilities
Liabilities
121611000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65085224
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58915375
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
65000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
59000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
556224000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
499715000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-494820000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-399783000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
61469000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
99995000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193814000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221606000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3067000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2220000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9384000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4124000
CY2021Q3 kala Product Revenue Cost
ProductRevenueCost
908000
us-gaap Operating Income Loss
OperatingIncomeLoss
-67247000
kala Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
-3000
kala Product Revenue Cost
ProductRevenueCost
2679000
kala Product Revenue Cost
ProductRevenueCost
1814000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25349000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23893000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
81034000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54602000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2881000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3468000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9101000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14955000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
29138000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
28062000
us-gaap Operating Expenses
OperatingExpenses
92814000
us-gaap Operating Expenses
OperatingExpenses
71371000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-26071000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25842000
us-gaap Operating Income Loss
OperatingIncomeLoss
-83430000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
16000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
51000
us-gaap Investment Income Interest
InvestmentIncomeInterest
92000
us-gaap Investment Income Interest
InvestmentIncomeInterest
451000
CY2021Q3 us-gaap Interest Expense
InterestExpense
2072000
CY2020Q3 us-gaap Interest Expense
InterestExpense
2157000
us-gaap Interest Expense
InterestExpense
6304000
us-gaap Interest Expense
InterestExpense
6419000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5395000
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2056000
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2106000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-11607000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-5968000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28127000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27948000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-95037000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73215000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.49
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.44
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65050481
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56030717
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
63766052
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50851167
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28127000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27948000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-95037000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73215000
CY2020Q3 kala Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
14000
kala Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
-4000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
128943000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28127000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27934000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95041000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73218000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
84270000
CY2021Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
9000
CY2021Q3 kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
333000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
906000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4087000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28127000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
61469000
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
746000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4268000
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
14000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-27948000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
106030000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
99995000
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
1171000
kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
41063000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
248000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1337000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13867000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4000
us-gaap Net Income Loss
NetIncomeLoss
-95037000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
61469000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29692000
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
388000
kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
12546000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
945000
us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
8475000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
125423000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1016000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9626000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3000
us-gaap Net Income Loss
NetIncomeLoss
-73215000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
106030000
us-gaap Profit Loss
ProfitLoss
-95037000
us-gaap Profit Loss
ProfitLoss
-73215000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
763000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
674000
kala Non Cash Operating Lease
NonCashOperatingLease
1711000
kala Non Cash Operating Lease
NonCashOperatingLease
1437000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5395000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1080000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
782000
us-gaap Share Based Compensation
ShareBasedCompensation
13340000
us-gaap Share Based Compensation
ShareBasedCompensation
9249000
us-gaap Variable Lease Cost
VariableLeaseCost
1621000
kala Amortization Of Discount On Available For Sale Securities
AmortizationOfDiscountOnAvailableForSaleSecurities
22000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
14000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3026000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4108000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1239000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
223000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6772000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1423000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4251000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-332000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
495000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4882000
kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-1300000
kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-950000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80331000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64775000
kala Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
874000
kala Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
1459000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
113592000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
76250000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
75426000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-115051000
CY2021Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2218000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
77782000
kala Payment Of Principal On Venture Debt Facility
PaymentOfPrincipalOnVentureDebtFacility
78010000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
41063000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
137969000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
26000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
24000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1585000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1961000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42394000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139906000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
37489000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39920000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89756000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98031000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127245000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58111000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127245000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58111000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2742000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12585000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124503000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45526000
kala Capital Expenditures Incurred But Not Yet Paid Accounts Payable
CapitalExpendituresIncurredButNotYetPaidAccountsPayable
34000
us-gaap Interest Paid Net
InterestPaidNet
5200000
us-gaap Interest Paid Net
InterestPaidNet
5636000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1211000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-494820000
CY2021Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
76272000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
76276000
CY2020 kala Investments Contractual Maturity Term
InvestmentsContractualMaturityTerm
P1Y
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1328000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
801000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
11888000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6437000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5531000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4210000
CY2021Q3 kala Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
18747000
CY2020Q4 kala Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
11448000
CY2021Q3 us-gaap Inventory Net
InventoryNet
7708000
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
11039000
CY2020Q4 us-gaap Inventory Net
InventoryNet
5229000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
6219000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8648000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9676000
CY2021Q3 kala Accrued Revenue Reserves
AccruedRevenueReserves
6696000
CY2020Q4 kala Accrued Revenue Reserves
AccruedRevenueReserves
5224000
CY2021Q3 kala Accrued Commercialization Cost
AccruedCommercializationCost
2125000
CY2020Q4 kala Accrued Commercialization Cost
AccruedCommercializationCost
2103000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
706000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926000
CY2021Q3 kala Accrued Contract Manufacturing
AccruedContractManufacturing
622000
CY2020Q4 kala Accrued Contract Manufacturing
AccruedContractManufacturing
336000
CY2021Q3 kala Development Costs Current
DevelopmentCostsCurrent
114000
CY2020Q4 kala Development Costs Current
DevelopmentCostsCurrent
154000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
554000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
552000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19465000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18971000
CY2019Q4 kala Number Of Vehicles Leased
NumberOfVehiclesLeased
65
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
450000
CY2019 kala Vehicles Leased Term
VehiclesLeasedTerm
P3Y
CY2021Q3 kala Number Of Additional Vehicles Leased
NumberOfAdditionalVehiclesLeased
54
kala Vehicles Leased Term
VehiclesLeasedTerm
P3Y
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1266000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1185000
us-gaap Operating Lease Cost
OperatingLeaseCost
3750000
us-gaap Operating Lease Cost
OperatingLeaseCost
3556000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
528000
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
404000
us-gaap Variable Lease Cost
VariableLeaseCost
1472000
CY2021Q3 us-gaap Lease Cost
LeaseCost
1794000
CY2020Q3 us-gaap Lease Cost
LeaseCost
1589000
us-gaap Lease Cost
LeaseCost
5371000
us-gaap Lease Cost
LeaseCost
5028000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1675000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1431000
us-gaap Operating Lease Payments
OperatingLeasePayments
4918000
us-gaap Operating Lease Payments
OperatingLeasePayments
4561000
CY2021Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P9Y8M12D
CY2020Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P10Y3M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.096
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.098
CY2021Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
80000000
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
75000000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2039000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3088000
CY2021Q3 kala Debt Instrument Exit Fees Of Total Principal Payments Value
DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue
530000
CY2020Q4 kala Debt Instrument Exit Fees Of Total Principal Payments Value
DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue
331000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
78491000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72243000
kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
215172
CY2020 kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
248505
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1936964
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.727
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.742
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0050
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0107
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.98
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3928000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4261000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13340000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9249000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
kala Purchase Obligations Fiscal Year Maturity Schedule Table Textblock
PurchaseObligationsFiscalYearMaturityScheduleTableTextblock
<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:101.95%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Years Ending December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2021 (remaining three months)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">1,090 </p></td></tr><tr><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">5,276 </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,285</p></td></tr><tr><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,875</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2025 (1)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,199</p></td></tr><tr><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Thereafter (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,925</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Total minimum purchase commitments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">46,650 </p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">(1) The minimum contract amount for the years included here are 75% of the actual dollar value of the units ordered for EYSUVIS and INVELTYS, in the aggregate, in the minimum requirement year immediately prior to the applicable minimum requirement year.<span style="white-space:pre-wrap;"> The table above assumes actual units are consistent with the purchase commitments for these years.</span></p>
CY2021Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
1090000
CY2021Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
5276000
CY2021Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
6285000
CY2021Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
7875000
CY2021Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
8199000
CY2021Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
17925000
CY2021Q3 us-gaap Contractual Obligation
ContractualObligation
46650000
kala Minimum Contract Amount Percent
MinimumContractAmountPercent
0.75

Files In Submission

Name View Source Status
0001558370-21-015987-index-headers.html Edgar Link pending
0001558370-21-015987-index.html Edgar Link pending
0001558370-21-015987.txt Edgar Link pending
0001558370-21-015987-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kala-20210930.xsd Edgar Link pending
kala-20210930x10q.htm Edgar Link pending
kala-20210930x10q009.jpg Edgar Link pending
kala-20210930x10q010.jpg Edgar Link pending
kala-20210930x10q011.jpg Edgar Link pending
kala-20210930x10q012.jpg Edgar Link pending
kala-20210930x10q013.jpg Edgar Link pending
kala-20210930x10q014.jpg Edgar Link pending
kala-20210930x10q_htm.xml Edgar Link completed
kala-20210930xex31d1.htm Edgar Link pending
kala-20210930xex31d2.htm Edgar Link pending
kala-20210930xex32d1.htm Edgar Link pending
kala-20210930xex32d2.htm Edgar Link pending
kala-20210930_cal.xml Edgar Link unprocessable
kala-20210930_def.xml Edgar Link unprocessable
kala-20210930_lab.xml Edgar Link unprocessable
kala-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending